Cordelia Alanis‐Garza
Papers
2
Total Citations
41
H-Index
2
About
Dr. Cordelia Alanis-Garza is a leading figure in the advancement of minimally invasive urologic and transplant surgery, with a primary focus on robotic-assisted techniques. Her work is pivotal in defining the comparative effectiveness of emerging surgical platforms. In a landmark 2022 systematic review and meta-analysis, she rigorously evaluated the novel da Vinci SP (single-port) platform against the established multiport system for radical prostatectomy, a cornerstone treatment for the most common cancer in men. This highly cited work (26 citations) provides crucial evidence on the SP console’s clinical utility since its FDA approval in 2018. Dr. Alanis-Garza has also made significant contributions to renal transplantation, authoring a key meta-analysis (15 citations) comparing robotic-assisted versus laparoscopic living donor nephrectomy. By synthesizing data on these minimally invasive approaches for end-stage renal disease, she has helped clarify the optimal surgical pathway for both donors and recipients. Her research directly informs surgical decision-making, blending rigorous methodology with a focus on improving patient outcomes in high-stakes surgical oncology and transplantation.
Research Focus
Key Achievements
Top Papers
- 1
- 2